TriSalus Life Sciences, Inc. (TLSI)
6.16
+0.33
(+5.66%)
USD |
NASDAQ |
Jan 15, 16:00
6.16
0.00 (0.00%)
After-Hours: 20:00
TriSalus Life Sciences SG&A Expense (TTM): 49.69M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ICU Medical, Inc. | 628.25M |
| Perspective Therapeutics, Inc. | 31.53M |
| InfuSystem Holdings, Inc. | 66.30M |
| Xtant Medical Holdings, Inc. | 74.03M |
| VolitionRX Ltd. | 13.97M |